Heat-Health Early Warning Systems
North America · 1 shared keyword
Updated
Reviewed by Chandani Patel
North America Disease Surveillance Systems Market Industry Trends and Forecast to 2034: Segmented by (Type, User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$3.75 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $4.18 Bn | — | — |
| 2025 (base) | $4.47 Bn | +$292.5 Mn | — |
| 2026 (forecast) | $4.78 Bn | +$313.0 Mn | +7% |
| 2027 (forecast) | $5.12 Bn | +$334.9 Mn | +14.5% |
| 2028 (forecast) | $5.48 Bn | +$358.4 Mn | +22.5% |
| 2029 (forecast) | $5.86 Bn | +$383.5 Mn | +31.1% |
| 2030 (forecast) | $6.27 Bn | +$410.3 Mn | +40.3% |
| 2031 (forecast) | $6.71 Bn | +$439.0 Mn | +50.1% |
| 2032 (forecast) | $7.18 Bn | +$469.8 Mn | +60.6% |
| 2033 (forecast) | $7.68 Bn | +$502.6 Mn | +71.8% |
| 2034 (forecast) | $8.22 Bn | +$537.8 Mn | +83.8% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $4.47 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $8.22 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 7.0% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Type and user (see all) |
| Key players | SAS Institute, Biobot Analytics, Ginkgo Bioworks, BlueDot, Esri (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Disease surveillance systems collect and analyse data to spot outbreaks early and guide public health action.
Key segments of the disease Surveillance Systems market include type (Syndromic Surveillance, Lab-Based Surveillance and Genomic Surveillance) and user (Governments, WHO and NGOs and Hospitals).
Global health goals, donor and government funding, better mobile technology and focus on preventing disease are driving the disease Surveillance Systems market.
Digital tools for community health, local manufacturing and public-private partnerships give the disease Surveillance Systems market room to grow.
Limited budgets, weak health systems in some regions, workforce shortages and supply chain gaps hold back the disease Surveillance Systems market.
The disease Surveillance Systems market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In the countries we cover here, rules for health software come from Health Canada (Canada)[1] and FDA (US)[2]. How care is paid for in these countries: provincial health insurance (Canada)[3] and Medicare and Medicaid (US)[4].
[1] Health Canada. Checked 14 Nov 2026.
[2] US Food and Drug Administration. Checked 14 Nov 2026.
[3] Health Canada. Checked 14 Nov 2026.
[4] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the disease Surveillance Systems market. Government digital health programs in North America are speeding up adoption.
What doctors and scientists are doing in Disease Surveillance Systems right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
North America · 1 shared keyword
North America · 1 shared keyword
North America · 1 shared keyword
North America · 1 shared keyword
North America · 1 shared keyword
North America
Medical Devices · North America
Medical Devices · North America
Pharmaceuticals · North America
OTC & Nutraceuticals · North America
Pharmaceuticals · North America
Medical Devices · North America